Delivery Order SPE2DB22D3301-SPE2DB24FY1VA
Award Date
3/4/24
Potential Completion Date
3/5/24
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,046.41 firm fixed-price delivery order is for the procurement of EPOGEN 10,000 units/mL vials, with a period of performance running through May 23, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of EPOGEN 10,000 units/mL vials, with a potential value of $1,178.00 and a completion date of February 20, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and...
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide Epogen 20,000 units/mL vials. The contract has a potential value of $1,325.40 and a period of performance through February 8, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver...
This federal contract award, with ID SPE2DB20D3103|SPE2DB23FP0R5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,711.97 delivery order is for EPOGEN 2,000 units/mL vials and has a firm fixed price. The contract has a completion date of July 21, 2023 and was awarded on July 20, 2023. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and is a critical supplier of pharmaceutical products and medical supplies...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,976.20 firm fixed price delivery order is for the supply of EPOGEN 20,000 units/mL vials, a specialty pharmaceutical product. The contract does not utilize any set-aside designations and has a completion date of February 26, 2024. AmerisourceBergen Drug Corp,...
This federal contract award, with the ID SPE2DB20D3103|SPE2DB24FN6X5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,447.84 firm fixed-price delivery order is for the supply of Epogen (epoetin alfa) 2,000 units/mL vials. The contract has an ultimate completion date of May 6, 2024 and was awarded on May 3, 2024. Amerisourcebergen, a for-profit organization, is registered in the System for Award Management (SAM.gov) and...
This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Epogen 3,000 units/mL vials. The contract has a ceiling value of $2,893.08 and is set to expire on February 7, 2025. The award was made by the Defense Logistics Agency (DLA) Troop Support Medical, which is the primary contracting agency for this procurement. This contract is part of a larger Indefinite Delivery Contract (IDC) held...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 10, 2022. The $2,070.64 Firm Fixed Price Delivery Order is for the supply of EPOGEN 20,000 units/mL vials. The award has an ultimate completion date of August 11, 2022 and was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award is for the delivery of pharmaceutical products, specifically EPOGEN 10MU/ML 1ML 6S, to support U.S. government agencies. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price type, valued at $3,495.28, and has an ultimate completion date of November 28, 2023. It was awarded by the Defense Logistics Agency (DLA) Troop Support...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 20,000 units/mL vials of the pharmaceutical product Epogen. The $1,845.97 order has a completion date of January 23, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, through its Corporate Office division, is a prime contractor that has received numerous awards from DLA Troop Support Medical to supply...